• Home
  • Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors.

Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors.

Author List
Desai A, Small EJ
Publication
Future oncology (London, England)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/57842741
Publication Year
2019
PubMed ID
31184937
Publication Title
Desai A, Small EJ. Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors. Future Oncol. 2019 Jul; 15(20):2337-2348.